| 23.68 -0.19 (-0.8%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.87 | 1-year : | 33.72 |
| Resists | First : | 24.71 | Second : | 28.87 |
| Pivot price | 22.95 |
|||
| Supports | First : | 22.31 | Second : | 20.82 |
| MAs | MA(5) : | 23.97 |
MA(20) : | 23 |
| MA(100) : | 22.59 |
MA(250) : | 20.16 |
|
| MACD | MACD : | 0 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 79.2  |
D(3) : | 83.5 |
| RSI | RSI(14): 53.5 |
|||
| 52-week | High : | 26.03 | Low : | 15.92 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PRVA ] has closed below upper band by 29.5%. Bollinger Bands are 32.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 23.86 - 24.01 | 24.01 - 24.11 |
| Low: | 22.64 - 22.82 | 22.82 - 22.95 |
| Close: | 23.43 - 23.71 | 23.71 - 23.9 |
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Tue, 15 Apr 2025
Assessing Privia Health Gr: Insights From 10 Financial Analysts - Benzinga
Mon, 14 Apr 2025
Insider Sell: Privia Health Group - MarketScreener
Wed, 09 Apr 2025
Privia Health stock target holds at $27 on Arizona expansion - Investing.com
Wed, 09 Apr 2025
Strategic Expansion: Privia Health Lands 70-Provider Arizona Partnership, Enters 15th State - Stock Titan
Wed, 09 Apr 2025
Privia joins Integrated Medical Services to enter Arizona (PRVA:NASDAQ) - Seeking Alpha
Tue, 08 Apr 2025
Privia Health to Report First Quarter 2025 Results on Thursday, May 8 - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 121 (M) |
| Shares Float | 103 (M) |
| Held by Insiders | 10.6 (%) |
| Held by Institutions | 102.1 (%) |
| Shares Short | 4,430 (K) |
| Shares Short P.Month | 4,660 (K) |
| EPS | 0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.28 |
| Profit Margin | 0.8 % |
| Operating Margin | 1.1 % |
| Return on Assets (ttm) | 0.9 % |
| Return on Equity (ttm) | 2.6 % |
| Qtrly Rev. Growth | 4.5 % |
| Gross Profit (p.s.) | 1.46 |
| Sales Per Share | 14.43 |
| EBITDA (p.s.) | 0.2 |
| Qtrly Earnings Growth | 24.5 % |
| Operating Cash Flow | 109 (M) |
| Levered Free Cash Flow | 105 (M) |
| PE Ratio | 215.27 |
| PEG Ratio | 0 |
| Price to Book value | 4.48 |
| Price to Sales | 1.64 |
| Price to Cash Flow | 26.11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|